TDE-33766-44367
3 vaccinations
2 coded responses
15 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 232 / VA
- Registered
- 2021-09-24
- Relationship
- Self
- Race
- White
- Ethnicity
- N/A
Timeline
-
2021-02-03
Dose 1 — Pfizer-BioNTech
-
2021-03-03
Dose 2 — Pfizer-BioNTech
-
2021-09-24
Registered in v-safe
-
2021-09-24
Dose 3 — Pfizer-BioNTech
- 2021-09-24
- 2021-09-25
-
2021-09-26
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: Good · Site: Redness, Swelling · Fatigue or tirednessFree text: Swollen lymph node under armpit on arm with shot.MedDRA releases: 2024-11 · check-in free text available
-
2021-09-28
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: Good · Site: PainFree text: Swollen lymph nodesMedDRA releases: 2024-11 · check-in free text available
- 2021-09-29
- 2021-09-30
- 2021-10-01
- 2021-10-08
- 2021-10-15
- 2021-10-22
- 2021-10-30
- 2021-11-07
- 2021-12-24
- 2022-03-27
- 2022-09-26
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-03 | Pfizer-BioNTech | No |
| 2 | 2021-03-03 | Pfizer-BioNTech | No |
| 3 | 2021-09-24 | Pfizer-BioNTech | No |
Free text
Release 9 — days 1–6 daily, dose 3
Systemic reaction (other): Swollen lymph node under armpit on arm with shot.
Systemic reaction (other): Swollen lymph nodes
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Lymphadenopathy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release